Barrington keeps Outperform rating on Paysign following ‘solid’ Q4 results

Barrington kept an Outperform rating and $5.50 price target on Paysign following the company’s "solid" Q4 earnings results, which included revenue that increased 21%, gross profit that increased 16%, "growth through the addition of new plasma centers," and guidance that was in-line with the firm’s expectations. The analyst added that Paysign "gained significant traction in patient affordability through doubling the number of active programs while diversifying the product portfolio into new verticals such as payroll, retail gift and GPR cards."